The Gonal-f ® RFF Redi-ject™ will be available in December 2013 in three pen sizes: 300 IU, 450 IU and 900 IU. For more information about the Gonal-f ® RFF Redi-ject™, please call Fertility Lifelines ...

Urofollitropin (Gonal -F FBM) is a human follicle-stimulating hormone, prescribed in combination with HCG hormone for infertility in women who have not responded to other therapy. It stimulates the ...

GENEVA, Switzerland, July 16 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that the Japanese Ministry of Health, Labor and Welfare has granted approval to ...

GONAL-f (follitropin alfa injection) is a recombinant human follicle-stimulating hormone (r-hFSH) approved for the treatment female infertility and a rare form of male infertility. Merck announced ...

DARMSTADT, Germany — The Food and Drug Administration has approved a pre-filled injector pen made by EMD Serono for infertile women, the company said Friday. The drug maker — the U.S. subsidiary of ...

Merck Serono announced that the FDA has approved EMD Serono‘s GONAL-f RFF Redi-ject (recombinant follitropin alfa) injection, a disposable prefilled drug injector pen indicated for the subcutaneous ...

Merck KGaA, whose sales of fertility drugs have benefited from competitor supply problems, will now have even more of its Gonal-f fertility drug to sell. The German company said today that it has ...

GENEVA, July 4, 2011 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that the European Commission (EC) has granted an approval for three pre-filled, ...

Haselmeier announces the launch by Merck of their GONAL-f® 2.0 prefilled pen following approval by EMA, the European Medicines Agency. Originally launched in 2011 by Merck, a leading science and ...